Mode
Text Size
Log in / Sign up
N/A Completed N=50 Screening

Shared Decision-Making: AFib 2gether Mobile App

Atrial Fibrillation New Onset
Source: ClinicalTrials.gov NCT04118270 ↗
Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcomePrimary: Patient MARS Scores — 4.51; 4.26; 4.24 score on a scale

Summary

Shared Decision-Making: AFib 2gether™ is a research study that focuses on a mobile application developed by Pfizer, Inc with consultation from Dr McManus' called AFib 2gether™. Through this app, patients can determine their risk of stroke due to atrial fibrillation and prioritize questions and concerns for discussion with their cardiology provider.

Outcome Measures

OutcomeResultp-value
PRIMARY
Patient MARS Scores
4.51; 4.26; 4.24
SECONDARY
Provider MARS Scores
4.19; 4.04; 3.76
SECONDARY
Reason Why the Patient Was Not on AC Prior to Their Appointment
16; 10; 5; 1; 2; 3
SECONDARY
Afib 2gether Accuracy Assessment
10

Eligibility Criteria

Inclusion Criteria

Providers:

  • Caring for at least 3 patients aged 18 years and older
  • Have at least 3 patients with International Classification of Diseases tenth revision (ICD-10) diagnostic code consistent with atrial fibrillation (AF) or atrial flutter
  • Have at least 3 patients with a CHA2DS2-VASc stroke risk score of 2 or more
  • Have at least 3 patients who are not on anticoagulation
  • Have at least 3 patients with upcoming appointments within the next 4 months

Patients:

  • Age 18+
  • Preferred language is English
  • Atrial fibrillation diagnosis
  • Chads vasc score 2 or higher
  • Not on anticoagulants
  • No watchman or atrial appendage closure
  • Had an ambulatory care center (ACC) cardiology appointment in the past 12 months
  • Future appointment in the next 4 months with the same provider

Exclusion Criteria

Providers:

  • Providers who do not care for at least 3 patients aged 18 years and older
  • Have patients that do not have an ICD-10 diagnostic code consistent with AF or atrial flutter
  • Does not have patients with a CHA2DS2-VASc stroke risk score of 2 or more
  • Their patients are on anticoagulation
  • Their 3 patients do not have an upcoming visit within the next 4 months

Patients:

  • Under the age of 18; patients
  • No ICD-10 diagnostic code consistent with AF or atrial flutter
  • Did not have a visit with a cardiovascular medicine specialist in the previous one year
  • Patients with a CHA2DS2-VASc score less than 2
  • Currently prescribed an anticoagulant
  • No upcoming cardiology visit in the next 3 months
  • Has a WATCHMAN device or left atrial appendage closure surgery
  • On hospice or for whom life expectancy is less than six months and patients
  • Bleeding episode or fall with injury in the last four weeks
  • Does not speak English
  • Prisoner
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04118270). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search